丽江股份：10月24日召开董事会会议

Group 1 - The core point of the article is that Lijiang Co., Ltd. held its 41st meeting of the 7th board of directors on October 24, 2025, via fax communication, where it reviewed the proposal for the company's Q3 2025 report [1] - For the first half of 2025, Lijiang Co., Ltd. reported that tourism accounted for 89.87% of its revenue, while other businesses contributed 10.13% [1] - As of the report, Lijiang Co., Ltd. has a market capitalization of 4.7 billion yuan [1] Group 2 - The article mentions that the Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year, highlighting a hot secondary market in biomedicine [1] - A dialogue with Lu Gang, a partner at Chuangdongfang Investment, indicates that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]